Huntington's disease is a hereditary disorder caused by a genetic mutation in the HTT gene, leading to progressive brain cell damage, affecting movement, cognition, and behavior, with no current cure.

A cure for Huntington’s disease may be a step closer after a study found brain changes linked to the condition could be detected 23 years before a diagnosis. Symptoms of the inherited disease ...

Symptoms of Huntington's disease appear late in life. Research reveals how DNA repeats grow toxic over time, explaining the ...

It suggests the treatment approach tried with mixed success in recent years isn't the only way to disrupt the disease ‒ and it lays a clear path for what may be a better one. Huntington's ...

Could viral infections play a role in Huntington's disease? Research suggests Apolipoprotein B mRNA editing catalytic proteins [APOBEC] proteins might be linked to DNA repeat expansions. APOBEC3A ...

For many people, the symptoms of Huntington's disease will not begin to show for ... and offered a glimmer of hope on possible future treatment. The new findings are now making waves ...

Huntington’s disease is horrible ... Current attempts to develop treatments for Huntington’s are based on the premise that all mutant huntingtin is toxic, and that its suppression with ...

Prom is returning to the Monona Terrace this February for its 13th year.The annual gala brings grown ups back to prom to ...

Huntington's disease kills a population of cells called ... "It's going to take much scientific work by many people to get to treatments that slow the expansion of DNA repeats," McCarroll said.

Along with researchers in the Faculty of Health Sciences and the Faculty of Science, Western projects received a total of $17 ...

Huntington's disease kills a population of cells called ... "It's going to take much scientific work by many people to get to treatments that slow the expansion of DNA repeats," McCarroll said.

H.C. Wainwright analyst Patrick Trucchio has reiterated their bullish stance on QURE stock, giving a Buy rating on January 21.Invest with ...